BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses

Huchun Li1, Masayuki Sekine, Seyha Seng

  • 1Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.

Plos One
|September 22, 2009
PubMed
Abstract

Insights

BRCA1 protein is crucial for regulating TGF-beta signaling, impacting cell growth and DNA repair. Loss of BRCA1 disrupts this pathway, particularly during oxidative stress, affecting cancer cell responses.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • BRCA1 is a key protein in DNA damage repair and cell cycle checkpoints.
  • Transforming growth factor-beta (TGF-beta) signaling regulates cell growth, apoptosis, and tumor cell invasiveness.
  • TGF-beta activates Smad signaling through its receptors, leading to transcriptional regulation.

Purpose of the Study:

  • To investigate the role of BRCA1 in modulating TGF-beta signaling under oxidative stress conditions.
  • To elucidate the interaction between BRCA1, Smad proteins, and TGF-beta signaling.
  • To understand how BRCA1 deficiency affects TGF-beta-mediated cellular responses.

Main Methods:

  • Utilized reporter assays (p3TP-Lux) to assess TGF-beta transactivation.
  • Employed Western blotting and siRNA to analyze protein expression and interactions (Smad3, Smad4).
  • Performed co-immunoprecipitation and immunofluorescence to study protein complex formation and localization (BRCA1, Smad3, Smad4) under oxidative stress (H2O2).

Main Results:

  • Wild-type BRCA1, but not mutated BRCA1, activated TGF-beta-mediated transactivation and increased Smad3 expression.
  • BRCA1 silencing reduced TGF-beta-induced Smad3 and Smad4 interaction.
  • BRCA1 interacted with Smad3 upon TGF-beta1 stimulation, an interaction enhanced by H2O2.
  • BRCA1 loss in HCC1937 cells led to decreased Smad3/Smad4 interaction and nuclear export of phosphor-Smad3 under oxidative stress.

Conclusions:

  • BRCA1 plays a critical role in mediating TGF-beta signaling pathways.
  • Loss or reduction of BRCA1 function impairs TGF-beta's growth-inhibiting activity during oxidative stress.
  • These findings highlight BRCA1's importance in cellular response to DNA damage and TGF-beta signaling in cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...